相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Yu Tang et al.
MOLECULAR NEUROBIOLOGY (2016)
Potential Role of Aspirin in the Prevention of Aneurysmal Subarachnoid Hemorrhage
Robert M. Starke et al.
CEREBROVASCULAR DISEASES (2015)
Upregulation of alphaB-crystallin expression in the substantia nigra of patients with Parkinson's disease
Yingjun Liu et al.
NEUROBIOLOGY OF AGING (2015)
Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice
Lv Yuqiang et al.
NEUROSCIENCE LETTERS (2015)
The association between infectious burden and Parkinson's disease: A case-control study
Xian-Le Bu et al.
PARKINSONISM & RELATED DISORDERS (2015)
Helicobacter pylori infection is associated with worse severity of Parkinson's disease
Ai Huey Tan et al.
PARKINSONISM & RELATED DISORDERS (2015)
Activation of Dopamine D2 Receptor Suppresses Neuroinflammation Through αB-Crystalline by Inhibition of NF-κB Nuclear Translocation in Experimental ICH Mice Model
Yang Zhang et al.
STROKE (2015)
Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration
Shanshan Cheng et al.
SCIENTIFIC REPORTS (2015)
Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson's disease
Y. Tang et al.
CELL DEATH AND DIFFERENTIATION (2014)
DJ-1 deficiency triggers microglia sensitivity dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline
Dorit Trudler et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Heterogeneous induction of microglia M2a phenotype by central administration of interleukin-4
Giovanna Pepe et al.
JOURNAL OF NEUROINFLAMMATION (2014)
The Prevalence of Parkinson's Disease: A Systematic Review and Meta-analysis
Tamara Pringsheim et al.
MOVEMENT DISORDERS (2014)
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease
Augusta Pisanu et al.
NEUROBIOLOGY OF DISEASE (2014)
Vascular Degeneration in Parkinson's Disease
Jian Guan et al.
BRAIN PATHOLOGY (2013)
Purinergic receptors in microglia: Functional modal shifts of microglia mediated by P2 and P1 receptors
Schuichi Koizumi et al.
GLIA (2013)
Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia
Lisa Fellner et al.
GLIA (2013)
Microglia/macrophage polarization dynamics in white matter after traumatic brain injury
Guohua Wang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Innate immunity in the Grid2Lc/+ mouse model of cerebellar neurodegeneration: glial CD95/CD95L plays a non-apoptotic role in persistent neuron loss-associated inflammatory reactions in the cerebellum
Beatrice Vernet-der Garabedian et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin
Wei Shao et al.
NATURE (2013)
Triggering of Inflammasome by Aggregated α-Synuclein, an Inflammatory Response in Synucleinopathies
Gaia Codolo et al.
PLOS ONE (2013)
General Anesthetics Inhibit LPS-Induced IL-1β Expression in Glial Cells
Tomoharu Tanaka et al.
PLOS ONE (2013)
Neuron - glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
GK Sheridan et al.
OPEN BIOLOGY (2013)
PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices
Jun Kim et al.
Experimental Neurobiology (2013)
Acacetin Protects Dopaminergic Cells against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Neuroinflammation in Vitro and in Vivo
Hyo Geun Kim et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Treatment for Helicobacter pylori infection and risk of parkinson's disease in Denmark
H. H. Nielsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein
Melanie B. Watson et al.
EXPERIMENTAL NEUROLOGY (2012)
PINK1 positively regulates IL-1β-mediated signaling through Tollip and IRAK1 modulation
Hyun Jung Lee et al.
JOURNAL OF NEUROINFLAMMATION (2012)
The Soluble Isoform of CX3CL1 Is Necessary for Neuroprotection in a Mouse Model of Parkinson's Disease
Josh M. Morganti et al.
JOURNAL OF NEUROSCIENCE (2012)
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Mark S. Moehle et al.
JOURNAL OF NEUROSCIENCE (2012)
Acacetin Attenuates Neuroinflammation via Regulation the Response to LPS Stimuli In Vitro and In Vivo
Sang Keun Ha et al.
NEUROCHEMICAL RESEARCH (2012)
PARKINSON'S DISEASE-LINKED LEUCINE-RICH REPEAT KINASE 2(R1441G) MUTATION INCREASES PROINFLAMMATORY CYTOKINE RELEASE FROM ACTIVATED PRIMARY MICROGLIAL CELLS AND RESULTANT NEUROTOXICITY
F. Gillardon et al.
NEUROSCIENCE (2012)
A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (Line 61) Mice
Marie-Francoise Chesselet et al.
NEUROTHERAPEUTICS (2012)
Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia
Beomsue Kim et al.
PLOS ONE (2012)
Microglia/Macrophage Polarization Dynamics Reveal Novel Mechanism of Injury Expansion After Focal Cerebral Ischemia
Xiaoming Hu et al.
STROKE (2012)
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Karin Wirdefeldt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2011)
Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: Roles of aging, superoxide, NADPH oxidase, and p38 MAPK
Xi-Jin Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
Mansoureh Hakimi et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
Lalida Rojanathammanee et al.
JOURNAL OF NEUROINFLAMMATION (2011)
CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease
Shi Zhang et al.
JOURNAL OF NEUROINFLAMMATION (2011)
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease
Mibel M. Pabon et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Delayed Dominant-Negative TNF Gene Therapy Halts Progressive Loss of Nigral Dopaminergic Neurons in a Rat Model of Parkinson's Disease
Ashley S. Harms et al.
MOLECULAR THERAPY (2011)
The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
Zhihua Liu et al.
NATURE IMMUNOLOGY (2011)
Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Parkinson's Disease
Angelika D. Manthripragada et al.
NEUROEPIDEMIOLOGY (2011)
Use of ibuprofen and risk of Parkinson disease
Xiang Gao et al.
NEUROLOGY (2011)
Neuroinflammation in Parkinson's disease
Etienne C. Hirsch et al.
PARKINSONISM & RELATED DISORDERS (2011)
Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease
Dawn Béraud et al.
PARKINSONISM & RELATED DISORDERS (2011)
Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient Mice
Ravi S. Akundi et al.
PLOS ONE (2011)
Lipopolysaccharide and Tumor Necrosis Factor Regulate Parkin Expression via Nuclear Factor-Kappa B
Thi A. Tran et al.
PLOS ONE (2011)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
Noriyuki Matsuda et al.
JOURNAL OF CELL BIOLOGY (2010)
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Agnes Gardet et al.
JOURNAL OF IMMUNOLOGY (2010)
Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson's disease
Ruth F. Villaran et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Anti-inflammatory drugs and risk of Parkinson disease A meta-analysis
Joshua J. Gagne et al.
NEUROLOGY (2010)
[C-11]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?
A. L. Bartels et al.
PARKINSONISM & RELATED DISORDERS (2010)
Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice
Xing-Long Gu et al.
MOLECULAR BRAIN (2010)
Naloxone-responsive acute dystonia and parkinsonism following general anaesthesia
I. A. Iselin-Chaves et al.
ANAESTHESIA (2009)
A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death
Kaoru Saijo et al.
CELL (2009)
Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1
Jens Waak et al.
FASEB JOURNAL (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding
Wendy Noble et al.
PRION (2009)
Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
Shaji Theodore et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
Tamy C. Frank-Cannon et al.
JOURNAL OF NEUROSCIENCE (2008)
Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats
Melissa K. McCoy et al.
MOLECULAR THERAPY (2008)
Synuclein activates microglia in a model of Parkinson's disease
Xiaomin Su et al.
NEUROBIOLOGY OF AGING (2008)
Nitrated α-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
Eric J. Benner et al.
PLOS ONE (2008)
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
Malu G. Tansey et al.
EXPERIMENTAL NEUROLOGY (2007)
Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striaturn of patients with Parkinson's disease
Toru Yasuda et al.
EXPERIMENTAL NEUROLOGY (2007)
Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons
Inmaculada Rite et al.
JOURNAL OF NEUROCHEMISTRY (2007)
A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation
Yoon Seong Kim et al.
FASEB JOURNAL (2007)
Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1β in the substantia nigra
Carina Cintia Ferrari et al.
NEUROBIOLOGY OF DISEASE (2006)
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease
Melissa K. McCoy et al.
JOURNAL OF NEUROSCIENCE (2006)
Control of microglial neurotoxicity by the fractalkine receptor
Astrid E. Cardona et al.
NATURE NEUROSCIENCE (2006)
Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: An in vivo microdialysis study
Vincenzo Di Matteo et al.
BRAIN RESEARCH (2006)
Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline
MJ Casarejos et al.
JOURNAL OF NEUROCHEMISTRY (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
In vivo evidence for microglial activation in neuro degenerative dementia
A. Cagnin et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Prevalence and incidence of Parkinson's disease in Europe
S von Campenhausen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
ML Block et al.
PROGRESS IN NEUROBIOLOGY (2005)
ATP mediates rapid microglial response to local brain injury in vivo
D Davalos et al.
NATURE NEUROSCIENCE (2005)
Role of inflammation in gastrointestinal tract in aetiology and pathogenesis of idiopathic parkinsonism
C Weller et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo
R Kortekaas et al.
ANNALS OF NEUROLOGY (2005)
Diagnostic staging of Parkinson's disease:: conceptual aspects
H Przuntek et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease
R Bandopadhyay et al.
BRAIN (2004)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system
M Tomás-Camardiel et al.
NEUROBIOLOGY OF DISEASE (2004)
Neuronal expression of CD22: Novel mechanism for inhibiting microglial proinflammatory cytokine production
RT Mott et al.
GLIA (2004)
Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
E Diguet et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Neuronal roles of the integrin-associated protein (IAP/CD47) in developing cortical neurons
T Numakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
EM Valente et al.
SCIENCE (2004)
Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease
I Kurkowska-Jastrzebska et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
A novel MyD-1 (SIRP-1α) signaling pathway that inhibits LPS-induced TNFα production by monocytes
RE Smith et al.
BLOOD (2003)
α-Synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy
F Mori et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-α, IL-1β and IFN-γ
A Castaño et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum
Y He et al.
BRAIN RESEARCH (2001)
Causes of death in a community-based study of Parkinson's disease
MK Beyer et al.
ACTA NEUROLOGICA SCANDINAVICA (2001)
Down-regulation of the macrophage lineage through interaction with OX2 (CD200)
RM Hoek et al.
SCIENCE (2000)
Immune modulatory effects of neural cell adhesion molecules on lipopolysaccharide-induced nitric oxide production by cultured glia
RCC Chang et al.
MOLECULAR BRAIN RESEARCH (2000)
Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function
GJ Wright et al.
IMMUNITY (2000)
Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
KP Mohanakumar et al.
BRAIN RESEARCH (2000)
Influence of neurons on lipopolysaccharide-stimulated production of nitric oxide and tumor necrosis factor-α by cultured glia
RCC Chang et al.
BRAIN RESEARCH (2000)
分享论文
